GLP1R and metabolic dysfunction-associated steatohepatitis: The GLP-1 and glucagon receptor dual agonist cotadutide significantly reduced hepatic steatosis, inflammation, and fibrosis in NASH male mice on a high fructose, trans-fat, and cholesterol diet [195].